Folliculitis with tapinarof, when it occurs, is generally mild, self-limiting, and rarely interferes with therapy

Document Type

Article

Publication Date

3-4-2021

Publication Title

Journal of the American Academy of Dermatology

PubMed ID

33676999

ePublication

ePub ahead of print

Share

COinS